Practice Point CME

Your Sorted CME/CE Activities

Number of search result: 22

Updates in High-Risk Myelodysplastic Syndromes (MDS)<br />Conversation 1 of 2

Activity Details

Updates in High-Risk Myelodysplastic Syndromes (MDS)<br />Conversation 1 of 2

Activity Summary:

High-risk myelodysplastic syndromes (MDS) pose a challenge in terms of diagnosis, risk stratification, and treatment. Additionally, in recent years, the clinical, molecular, cellular, and immunological factors associated with high-risk MDS have become clearer.

This has led to several updates in the diagnosis and management of high-risk MDS, which will be discussed by Dr. Gail Roboz, Dr. Courtney DiNardo, and Dr. Rami Komrokji. The expert faculty will also review clinical case scenarios to guide participants in integrating recent updates in high-risk MDS.

Faculty:Courtney DiNardo, MD, MSCE, Rami Komrokji, MD and Gail Roboz, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:November 22, 2021

Release Date:November 18, 2021

Expiration Date: September 30, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in Hematology/Oncology: Leukemic Transformation of Myelodysplastic Syndromes: Identification, Evaluation and Management Issues

Activity Details

Conversations in Hematology/Oncology: Leukemic Transformation of Myelodysplastic Syndromes: Identification, Evaluation and Management Issues

Activity Summary:

These certified AMA/ANCC/ACPE activities feature a discussion among three experts that will review the current and emerging treatment landscape of high-risk myelodysplastic syndromes (MDS). The program includes two activities that will feature the faculty discussing recent updates in the standard of care for high-risk MDS and what is on the horizon for high-risk MDS.

Faculty:Faculty varies

Accreditation Type:AMA, ANCC and ACPE

Launch Date:

Release Date:

Expiration Date:

Estimated Time to Complete Activity:

ACCESS THIS ACTIVITY

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia

Activity Details

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia

Activity Summary:
Immune thrombocytopenic purpura (ITP) is a hematological autoimmune disorder characterized by low platelet count in the blood, which may lead to bruising and bleeding. For many years, immune-modulating therapies, such as corticosteroids, immunoglobulins (IVIG and anti-RhD), and rituximab, were the mainstays of treatment in ITP. Since 2008, the approval of thrombopoietin-receptor agonists (TPO-RAs) including a second-generation oral TPO-RA and a spleen tyrosine kinase (Syk) inhibitor, revolutionized the treatment landscape of ITP by opening new and highly effective avenues of treatment. This landscape will be further transformed with a sizable clinical pipeline including inhibitors of CD20, CD40, neonatal Fc receptor (FcRn), bruton’s tyrosine kinase (BTK), and Syk signaling.

This slide kit is designed to keep busy clinicians abreast of the emerging evidence for available treatments and the novel therapy pipeline, to optimize the treatment and care for patients with ITP.

Faculty:Hanny Al-Samkari, MD

Accreditation Type:AMA and ANCC

Launch Date:August 30, 2021

Release Date:August 30, 2021

Expiration Date: July 31, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Independent Coverage of the 2021 International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress

Activity Details

Independent Coverage of the 2021 International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress

Activity Summary:
Effective strategies for immune thrombocytopenia (ITP) continue to evolve and clinicians are often challenged when presented with clinical scenarios not adequately addressed by current treatment guidelines. Many times treatment decisions necessitate consideration of the most recent clinical trial data.

These educational Clinical Clips will highlight important advances in the medical management of patients with ITP based on data presented at the 2021 International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress.

Faculty:Cindy Neunert, MD, MSCS

Accreditation Type:AMA and ANCC

Launch Date:July 19, 2021

Release Date:July 19, 2021

Expiration Date: June 30, 2022

Estimated Time to Complete Activity:.25 hours per clip

ACCESS THIS ACTIVITY

Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*

Activity Details

Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*

Activity Summary:
Immunotherapy approaches have revolutionized the treatment of melanoma and ongoing studies are focused on improving outcomes and reducing toxicities with existing and novel therapies. To ensure updated ongoing care for patients, clinicians need to stay abreast with recent clinical trial evidence from different settings of melanoma treatment.

This educational Clinical Clip will highlight important advances in immunotherapy approaches for melanoma based on data presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.

Faculty:Hussein Tawbi, MD, PhD

Accreditation Type:AMA

Launch Date:July 16, 2021

Release Date:July 9, 2021

Expiration Date: June 30, 2022

Estimated Time to Complete Activity:0.25 hours

ACCESS THIS ACTIVITY

INTERACTIVE CASE STUDIES IN HEMATOLOGY / ONCOLOGY: Individualizing Diagnosis, Treatment and Management of Multiple Myeloma

Activity Details

INTERACTIVE CASE STUDIES IN HEMATOLOGY / ONCOLOGY: Individualizing Diagnosis, Treatment and Management of Multiple Myeloma

Activity Summary:
These certified CME interactive case presentations will review recent clinical trial and published data that will support the appropriate management and treatment decisions recommended by the expert faculty in multiple myeloma.

During these interactive case presentations Dr. Joseph Mikhael and Dr. Nina Shah will address scenarios focusing on a newly diagnosed patient, early relapse, late relapse and patient requiring maintenance therapy, will be presented and discussed. The activity will be supported by downloadable slides that have the key discussion/teaching points.

Faculty:Joseph Mikhael, MD and Nina Shah, MD

Accreditation Type:AMA

Launch Date:June 15, 2021

Release Date:June 15, 2021

Expiration Date: May 31, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Independent Coverage of the 2021 European Hematology Association (EHA) Virtual Congress*

Activity Details

Independent Coverage of the 2021 European Hematology Association (EHA) Virtual Congress*

Activity Summary:
Effective strategies for immune thrombocytopenia (ITP) continue to evolve and clinicians are often challenged when presented with clinical scenarios not adequately addressed by current treatment guidelines. Many times treatment decisions necessitate consideration of the most recent clinical trial data.

These educational Clinical Clips will highlight important advances in the medical management of patients with ITP based on data presented at the 2021 European Hematology Association (EHA) Virtual Congress.

Faculty:James Bussel, MD

Accreditation Type:AMA and ANCC

Launch Date:June 11, 2021

Release Date:June 11, 2021

Expiration Date: May 31, 2022

Estimated Time to Complete Activity:.25 hours per clip

ACCESS THIS ACTIVITY

Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*

Activity Details

Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*

Activity Summary:
Novel biomarker-driven approaches for the treatment of advanced/metastatic non-small cell lung cancer (NSCLC) continue to evolve at a rapid pace. Therefore, clinicians need to stay abreast with recently presented clinical trial data to provide updated molecular testing-based therapies for their patients with NSCLC.

These educational Clinical Clips will highlight important advances in biomarker-driven targeted therapy approaches for NSCLC based on data presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.

Faculty:Mark A. Socinski, MD

Accreditation Type:AMA

Launch Date:June 8, 2021

Release Date:June 8, 2021

Expiration Date: May 31, 2022

Estimated Time to Complete Activity:0.50 hours

ACCESS THIS ACTIVITY

Conversations in Oncology: Updates in the Treatment of Graft Versus Host Disease

Activity Details

Conversations in Oncology: Updates in the Treatment of Graft Versus Host Disease

Activity Summary:
This certified CME/CNE activity features a recorded discussion among three experts reviewing new therapies and protocols to improve outcomes in (Graft Versus Host Disease) GVHD.

This educational activity will focus on the new therapies and protocols to improve outcomes in GVHD. Data will be reviewed and analyzed by expert faculty while discussing common patient scenarios and best practices in treatment.

Faculty:James Ferrara, MD, Mark A. Schroeder, MD and Celalettin Ustun, MD

Accreditation Type:AMA and ANCC

Launch Date:March 16, 2021

Release Date:March 16, 2021

Expiration Date: February 28, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

CONVERSATIONS IN HEMATOLOGY / ONCOLOGY: Clinical Focus on Myeloproliferative Neoplasms (MPNs)

Activity Details

CONVERSATIONS IN HEMATOLOGY / ONCOLOGY: Clinical Focus on Myeloproliferative Neoplasms (MPNs)

Activity Summary:

This certified CME/CNE activity features a recorded discussion among three experts that reviews the latest research and options for the management of patients with MPNs.

This activity will feature Dr. Srdan Verstovsek, Dr. Ruben Mesa and Dr. John Mascarenhas discussing the standard of care for Polycythemia Vera and Myelofibrosis. The discussion will be supplemented by slides based on key discussion points which are available for download.

Faculty:Srdan Verstovsek, MD, Ruben A. Mesa, MD and John Mascarenhas, MD

Accreditation Type:AMA and ANCC

Launch Date:February 10, 2021

Release Date:February 10, 2021

Expiration Date: January 31, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

CONVERSATIONS IN ONCOLOGY: Immunotherapy Trials in Early Stage Lung Cancer: Expert Opinion on Recent Updates

Activity Details

CONVERSATIONS IN ONCOLOGY: Immunotherapy Trials in Early Stage Lung Cancer: Expert Opinion on Recent Updates

Activity Summary:

This certified CME/CNE activity features a recorded discussion among three lung cancer experts that reviews the latest options for the management of early stage lung cancer.

This activity will feature Dr. Jack West, Dr. Mark Socinski and Dr. Jamie Chaft discussing the standard of care for early stage lung cancer and recent data on the early use of immunotherapy for adjuvant or neoadjuvant use in early lung cancer. The discussion will be supplemented by slides based on the discussion which are available for download.

Faculty:Howard L. (Jack) West, MD, Mark A. Socinski, MD and Jamie E. Chaft, MD

Accreditation Type:AMA and ANCC

Launch Date:December 21, 2020

Release Date:December 21, 2020

Expiration Date: November 30, 2021

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Acute Leukemia Interactive Case Studies - Establishing Acute Leukemia Clinical Recommendations for Community Based Oncologists

Activity Details

Acute Leukemia Interactive Case Studies - Establishing Acute Leukemia Clinical Recommendations for Community Based Oncologists

Activity Summary:

These certified CME/CNE interactive case presentations will review the latest management strategies and treatment options for the management of acute leukemia.

During these interactive case studies Dr. Richard M. Stone will address the most clinically relevant data on Acute Lymphoblastic Leukemia and Dr. Farhad Ravandi address the most clinically relevant data on Acute Myeloid Leukemia. Each Interactive Case has thought-provoking questions from the faculty built into them giving users the opportunity to test their understanding of the material presented.

Faculty:Richard M. Stone, MD and Farhad Ravandi-Kashani, MD

Accreditation Type:AMA and ANCC

Launch Date:December 10, 2020

Release Date:December 4, 2020

Expiration Date: December 3, 2021

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Independent Coverage from the 62nd American Society of Hematology (ASH) Annual Meeting*

Activity Details

Independent Coverage from the 62nd American Society of Hematology (ASH) Annual Meeting*

Activity Summary:
Effective strategies for immune thrombocytopenia (ITP) continue to evolve and clinicians are often challenged when presented with clinical scenarios not adequately addressed by current treatment guidelines. Many times treatment decisions necessitate consideration of the most recent clinical trial data.

These educational Clinical Clips will highlight important advances in the medical management of patients with ITP based on data presented at the 62nd American Society of Hematology (ASH) Annual Meeting through a series of two ‘what you need to know in 5-minutes’ videos.

Faculty:Hanny Al-Samkari, MD

Accreditation Type:AMA and ANCC

Launch Date:December 5, 2020

Release Date:December 5, 2020

Expiration Date: November 30, 2021

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Case-based Treatment Strategies in Patients with Chronic Immune Thrombocytopenia

Activity Details

Case-based Treatment Strategies in Patients with Chronic Immune Thrombocytopenia

Activity Summary:
Treatment choices for chronic immune thrombocytopenia (ITP) are complicated by the heterogeneity of the disease and the inability not only to diagnose it but also to objectively predict patient responses to treatment and outcomes. With lack of head-to-head clinical trial comparisons to guide therapeutic options and sequencing of treatment strategies, as well as the development of emerging agents, expert opinion is critical in guiding clinical decision-making. Furthermore, ITP in the elderly and pregnant patient poses considerable challenges, so specific individualized management strategies ideally should be considered to optimize outcomes.

Using patient case studies, James Bussel, MD and Hanny Al-Samkari, MD discuss real-life management of patients with chronic ITP.

Faculty:James Bussel, MD and Hanny Al-Samkari, MD

Accreditation Type:Expired Activity

Launch Date:December 2, 2020

Release Date:November 10, 2020

Expiration Date: October 31, 2021

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma

Activity Details

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma

Activity Summary:
Treatment paradigms for multiple myeloma have changed substantially over the last years with many advances in novel therapeutic approaches.

Presented by Dr. Joseph Mikhael of the Translational Genomics Research Institute, City of Hope Cancer Center, and Chief Medical Officer of the International Myeloma Foundation, the archived recording of the certified-CME/CNE 1-hour live webcast will cover recent updates in the standard of care and review the latest approved products and new research for the management of multiple myeloma.

Faculty:Joseph Mikhael, MD

Accreditation Type:Expired Activity

Launch Date:October 1, 2020

Release Date:September 30, 2020

Expiration Date: August 31, 2021

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Evolving Treatment Strategies in Prostate Cancer: An Interactive Case Studies Program

Activity Details

Evolving Treatment Strategies in Prostate Cancer: An Interactive Case Studies Program

Activity Summary:
New frontiers for prostate cancer therapy continue to be explored, as underscored by evolving principles and new agents in development. To deliver state-of-the-art care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations. There is a need for those who treat prostate cancer to consider expert opinion and guidelines in the context of the needs and beliefs of individual patients, to tailor therapy, and achieve best results.

This educational program will review metastatic, hormone-sensitive prostate cancer, non-metastatic, castration-resistant prostate cancer, and prostate cancer local recurrence.

Faculty:Daniel Petrylak, MD and Srinivas Vourganti, MD

Accreditation Type:Expired Activity

Launch Date:September 17, 2020

Release Date:September 17, 2020

Expiration Date: August 31, 2021

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Independent Coverage from the American Association for Cancer Research (Virtual Annual Meeting)*

Activity Details

Independent Coverage from the American Association for Cancer Research (Virtual Annual Meeting)*

Activity Summary:
Advances in cancer research unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest and most relevant clinical data on the advances in the treatment and management of ovarian cancer with a series of ‘what you need to know in 5-minutes’ videos from data presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting.

Faculty:Robert L. Coleman, M.D., FACOG, FACS

Accreditation Type:Expired Activity

Launch Date:April 28, 2020

Release Date:April 28, 2020

Expiration Date: March 31, 2021

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Advances in the Management of Chronic Immune Thrombocytopenia in Adults - Updated 9/1/20

Activity Details

Advances in the Management of Chronic Immune Thrombocytopenia in Adults - Updated 9/1/20

Activity Summary:
Chronic immune thrombocytopenia (ITP) is one of the most common causes of thrombocytopenia in adults. Diagnosis of ITP remains one of exclusion, and differential diagnosis with secondary forms is crucial to exclude other forms of thrombocytopenia, which may require a different therapeutic approach. Furthermore, chronic symptomatic ITP necessitates second-line treatments based on highly individualized considerations. Advances in the understanding of the pathogenesis have led to novel therapeutic targets, such as the thrombopoietin receptor agonists to aid in this personalized approach.

These educational Mini Modules will outline recent data on current and emerging treatment options for chronic ITP, including FcRn and spleen tyrosine kinase inhibitors.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:Hanny Al-Samkari, MD

Accreditation Type:Expired Activity

Launch Date:July 31, 2019

Release Date:July 31, 2019

Expiration Date: December 31, 2020

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Atlanta Breast Cancer Symposium Enduring Video Archive

Activity Details

Atlanta Breast Cancer Symposium Enduring Video Archive

Activity Summary:
We are pleased to have recently held the Atlanta Breast Cancer Symposium (ABCS) on April 13, 2019 at the InterContinental Buckhead in Atlanta, Georgia.

There are multiple professional education opportunities in breast cancer across the country. The difference of the ABCS with others is the emphasis in the molecular basis of breast cancer to be applied from early detection to management of advanced disease, beyond induction treatment.

The objective of the symposium is to educate the oncology community on the rapidly evolving field of breast cancer from molecular biology to the development and clinical application of highly specific molecules to interfere with the cellular machinery allowing the cancer cells to survive, proliferate, and spread.

These certified CME/CE enduring video archives, with panel discussions, provide access to the conference including clinical presentation and interactive panel discussions with the faculty and audience.

We hope you enjoy this activity!

Faculty:Rodolfo Bordoni, MD

Accreditation Type:Expired Activity

Launch Date:May 16, 2019

Release Date:May 16, 2019

Expiration Date: April 30, 2020

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Thrombocytopenia in Chronic Liver Disease

Activity Details

Thrombocytopenia in Chronic Liver Disease

Activity Summary:
Thrombocytopenia is a common manifestation among patients with chronic liver disease. In the setting of advanced liver disease, thrombocytopenia may negatively impact patient care by interfering with diagnostic and therapeutic procedures. The development of thrombopoietin agonists has the potential to provide clinicians with new options to improve patient care. However, current guidelines provide limited guidance on the optimal approach to increase platelet counts in patients with chronic liver disease.

These educational Mini Modules will outline the pathophysiologic mechanisms, platelet threshold levels, and other factors that impact the decision to initiate treatment for thrombocytopenia. In addition, the benefits and limitations of current and emerging therapeutic options will be discussed.

Faculty:Fred Poordad, MD

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Updates in High-Risk Myelodysplastic Syndromes (MDS)<br />Conversation 1 of 2

Conversations in Hematology/Oncology: Leukemic Transformation of Myelodysplastic Syndromes: Identification, Evaluation and Management Issues

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia

Independent Coverage of the 2021 International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress

Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*

INTERACTIVE CASE STUDIES IN HEMATOLOGY / ONCOLOGY: Individualizing Diagnosis, Treatment and Management of Multiple Myeloma

Independent Coverage of the 2021 European Hematology Association (EHA) Virtual Congress*

Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*

Conversations in Oncology: Updates in the Treatment of Graft Versus Host Disease

CONVERSATIONS IN HEMATOLOGY / ONCOLOGY: Clinical Focus on Myeloproliferative Neoplasms (MPNs)

CONVERSATIONS IN ONCOLOGY: Immunotherapy Trials in Early Stage Lung Cancer: Expert Opinion on Recent Updates

Acute Leukemia Interactive Case Studies - Establishing Acute Leukemia Clinical Recommendations for Community Based Oncologists

Independent Coverage from the 62nd American Society of Hematology (ASH) Annual Meeting*

Case-based Treatment Strategies in Patients with Chronic Immune Thrombocytopenia

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma

Evolving Treatment Strategies in Prostate Cancer: An Interactive Case Studies Program

Independent Coverage from the American Association for Cancer Research (Virtual Annual Meeting)*

Advances in the Management of Chronic Immune Thrombocytopenia in Adults - Updated 9/1/20

Atlanta Breast Cancer Symposium Enduring Video Archive

Thrombocytopenia in Chronic Liver Disease